Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

NCT02874794 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure and Reduced Ejection Fraction

Interventions

DRUG: LCZ696 (sacubitril/valsartan)
DRUG: Enalapril
DRUG: Placebo of Enalapril
DRUG: Placebo of LCZ696

Sponsor

Novartis Pharmaceuticals